Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.2M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
34.5M
-
Shares change
-
-2.19M
-
Total reported value, excl. options
-
$209M
-
Value change
-
-$12.8M
-
Put/Call ratio
-
0.18
-
Number of buys
-
52
-
Number of sells
-
-40
-
Price
-
$6.05
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q3 2018
122 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q3 2018.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.5M shares
.
Largest 10 shareholders include BlackRock Inc. (3.69M shares), RENAISSANCE TECHNOLOGIES LLC (3.54M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3M shares), JPMORGAN CHASE & CO (2.77M shares), Vanguard Group Inc (2.25M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.87M shares), DIMENSIONAL FUND ADVISORS LP (1.64M shares), WS MANAGEMENT LLLP (1.15M shares), Castle Hook Partners LP (1.08M shares), and STATE STREET CORP (934K shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.